Castro-Balado, A.; Cuartero-MartÃnez, A.; Pena-Verdeal, H.; Hermelo-Vidal, G.; Schmidt, A.; Montero, B.; Hernández-Blanco, M.; Zarra-Ferro, I.; González-Barcia, M.; Mondelo-GarcÃa, C.;
et al. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence. Pharmaceutics 2023, 15, 2589.
https://doi.org/10.3390/pharmaceutics15112589
AMA Style
Castro-Balado A, Cuartero-MartÃnez A, Pena-Verdeal H, Hermelo-Vidal G, Schmidt A, Montero B, Hernández-Blanco M, Zarra-Ferro I, González-Barcia M, Mondelo-GarcÃa C,
et al. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence. Pharmaceutics. 2023; 15(11):2589.
https://doi.org/10.3390/pharmaceutics15112589
Chicago/Turabian Style
Castro-Balado, Ana, Andrea Cuartero-MartÃnez, Hugo Pena-Verdeal, Gonzalo Hermelo-Vidal, Anja Schmidt, Belén Montero, Manuela Hernández-Blanco, Irene Zarra-Ferro, Miguel González-Barcia, Cristina Mondelo-GarcÃa,
and et al. 2023. "Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence" Pharmaceutics 15, no. 11: 2589.
https://doi.org/10.3390/pharmaceutics15112589
APA Style
Castro-Balado, A., Cuartero-MartÃnez, A., Pena-Verdeal, H., Hermelo-Vidal, G., Schmidt, A., Montero, B., Hernández-Blanco, M., Zarra-Ferro, I., González-Barcia, M., Mondelo-GarcÃa, C., Giráldez, M. J., Yebra-Pimentel, E., Otero-Espinar, F. J., & Fernández-Ferreiro, A.
(2023). Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence. Pharmaceutics, 15(11), 2589.
https://doi.org/10.3390/pharmaceutics15112589
